您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:贝康医疗-B2024 中期报告 - 发现报告

贝康医疗-B2024 中期报告

2024-09-27港股财报S***
AI智能总结
查看更多
贝康医疗-B2024 中期报告

: 2170 2024 目錄 2 4 5 21 29 30 31 32 34 35 36 48 20248292024829 218A3101 24840 H 183171712–1716 1526 77334 108 18127 2170 www.basecare.cn 718 LiveLiveBrowserLiveMorphologyLiveStorageLive ViewLiveIntelligence LiveBrowserLiveMorphologyLiveViewLive StorageLive Intelligence 1.Live Browser PCRPGTLiveBrowserPGTPGT-A72%6.9%PGT-MPGT-SRDA500PGT-APGT-A 2.Live Morphology DNA4075%40%(CASA)LiveMorphology50Live Morphology 3.Live View 6LiveView 4.Live Storage 51,000LiveStorage3-5 5.Live Intelligence LiveIntelligenceiARMS+(IoT)iARMSiARMS **********1.352.3. PGT-A PGT-A(CCS)SDWGAPGT-A100%PGT-A72.0%6.9%45.0%32.0%(Schoolcraft et al.2010,Wang et al.2010)PGT-A2024630PGT-A18.7966.8% PGT-M PGT-MPGT-MDNADNA(SNP)SNPPGT-MSNPPCRMSLCapSNPPGT-M60%PGT-M202432024 PGT-SR PGT-SRPGT-MPGT-SRPGT-SRReTSeqPGT-SR20212PGT-SR202342025 (DA500) DA50010GB150GBDA500PGT2023920233221281 BS1000C BS1000C96BS1000C PGT-APGT-MPGT-SR PGTPGT-APGT-MPGT-SRPGT-A2022PGT-MPGT-SR20242025PGT (Geri®) Geri®50011CO2(Geri®)20202180490CEFDATGA (Gems) GemspHGaviGems(HSA)2013GemsGemsGemsCEFDATGA2025Gems (BCT38) 2020CE20221120222221946 (BSG800ABSG800C) (BSG800ABSG800C)2020CE2024920242221830 (BKA210) 2023102024 (Gavi) GaviGaviCE2026 (iARMS) iARMS+iARMSiARMSiARMS 2024471,62821,50350,125 GMP400,000ISO13485:2016ISO14644-1ISO7GMP (i)Computationaland Structural Biotechnology Journal(IF 6.2)MultidimensionalMorphological Analysis of Live Sperm based on Multiple-target Tracking (ii)— CNV-plus (iii)MolecularGenetics&Genomic MedicinePreimplantationgenetic testing as a means ofpreventing hereditary congenital myasthenic syndrome caused by RAPSNWESPGT-M (iv)BMCMedical GenomicsDevelopmentof preimplantation genetic testing for monogenicreferencematerials using next-generation sequencing12DNA(gDNA)4PGT-M (v)Molecular Genetics & Genomic MedicineIdentification and interruption of inheritance offamilial cryptic translocationsA case report 2024630118125571665 202463070202363018548300BMX203040600 20246308511573%30050%50202363020% BMXBMXPGT20242024 202482920248292024829 (i)PGT (ii)500(iii)KOLPGT(iv)(v) 18A.08(3) 202363085.545.8%2024630124.7(i)BMXBMX(ii)PGT (i)(ii)(iii)(iv) 202363052.028.7%202463066.9BMX 202363033.672.3%202463057.9202363039.2%202463046.4%BMX 202363047.747.1%202463025.2 202363039.329.0%202463050.7BMX 202363036.2122.1%202463080.4BMX 202363063.79.3%202463069.6PGT-MPGT-SRBMXBMX (i)(ii)202363020246300.13.72024630 20236304.220246301.4 2023123194.12.2%202463096.2 20231231174.04.0%2024630180.92023 20231231179.716.8%2024630149.5 202312311,215.28.3%20246301,114.7 2024630152.422.41303.45%LPR175.93.65%3.90%LPR 1,898.720211116202247— 2024630 202463020231231 —— 175.92024630 100%2024630 202463052820231231586 202463092.3202363065.1 2024630 2024630XV352 (1)202463058.31% (2)2024630() (3)2024630273,526,000 (4)2024630190,812,165 2024630352 2024630336 (1)2024630HH SPR-XIV CY Holdings LimitedHH CYHH SPR-XIV CY Holdings LimitedHHSPR-XIVHoldings L.P.HHHoldingsHHHoldingsHillhouseFund IV,L.P.HillhouseFund IV,L.P.Hillhouse Investment Management, Ltd. (2)2024630OrbiMed Capital LLC(i) The Biotech Growth Trust Plc2,204,900H(ii) OrbiMed Genesis MasterFund,L.P.980,000H(iii)OrbiMed New Horizons Master Fund,L.P.514,500H(iv)OrbiMed PartnersMaster Fund Limited4,417,100HOrbiMed Capital LLCThe BiotechGrowth Trust PlcOrbiMed Genesis Master Fund, L.P.OrbiMed New Horizons Master Fund, L.P.OrbiMed Partners Master FundLimited (3)202463058.31% (4)202463070.00% (5)2024630 (6)202463043.88%72.58%202463051.00%35.00%99.00% (7)2024630273,526,000 (8)2024630H82,713,8352024630190,812,165 2024630336 13.51B(1) 2023 2024630C.2.1 1,898.71,584.1 20211116202247— 2023630 2024630 13.2013.21 13.2217.07 3.10(2)3.21 2024630 24102024630 2024829 304720246303434 2410 202463034 108 2024829 截 至2024年6月30日 止 六 個 月—未 經 審 核 11121212 1 201012142020811 H202128 2 342024829 202320243 34 2023 241029 20231231202312312024328 3 12020120221677— 4 (a) 15 ——— —— 4 (a) ———— (b) 10% ABC *10% (c) 8 4 (c) (i) 7 (a) —— (i) 25%25% 30%2024630 (ii) 15%202311615% 100%20241231 (b) 2024630252,00033,223,0002023 8 2024630119,912,000202363061,369,000273,526,0002023630273,526,000 20242023630 9 20246307,206,00020236309,437,00015,493,000202363049,484,000 10 (i)(ii)(ii) (i)2022810TruMedHealth Innovation Fund LP1.5010,690,000 2024630645,0004,600,00020231231585,0003,997,0001.1%202312311.0%2024630660,0002023630123,00017 (ii)16(a) 11 661212181824 202463020231231441,969,000469,634,000 13 14 (b) 16 (a) 13 16 (a) 20246302023 2024 11630 16 (a) 2024 630 (b) 202463020231231 17 2024630 ——10 18